Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
13800
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数13,800Shares
13,800 new shares
発行済株式総数
13,800 shares delivered during the month; exercise ratio subject to exercise restrictions: 0.05%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise prices during the subject month were ¥372.7, ¥373.8 and ¥373.6. Details of the adjustment provisions and the floor price: Not disclosed
Number of Stock Acquisition Rights
The total number issued can be calculated from the statement that 138 rights represented 0.36% of the total issued, but the total number issued is not explicitly stated. 138 rights were exercised during the month, and 38,293 remained unexercised at month-end.
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Timing 9 March 2026 / Type Issuance of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 13,800 new shares |
| Dilution Rate | 13,800 shares delivered during the month; exercise ratio subject to exercise restrictions: 0.05% |
| Total number of issued shares | 29,171,600 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | The exercise prices during the subject month were ¥372.7, ¥373.8 and ¥373.6. Details of the adjustment provisions and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | The total number issued can be calculated from the statement that 138 rights represented 0.36% of the total issued, but the total number issued is not explicitly stated. 138 rights were exercised during the month, and 38,293 remained unexercised at month-end. |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Timing 9 March 2026 / Type Issuance of the Third Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company is reporting the monthly exercise status of its Series 3 Stock Acquisition Rights for May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.